Bafna Pharmaceuticals shareholding pattern
BAFNAPH
112.75
3.20 (-2.76%)Last updated on 20 Feb, 2026 | 15:29 IST
BUYSELL
Free Demat with Zero AMC*
Summary
For Year 2025-26, Bafna Pharmaceuticals reports the following shareholding: Total Promoters at 75%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 9.34%, Domestic Institutional Investors at 0%, and Retail at 15.66%. This breakdown provides a quick snapshot of ownership distribution for Bafna Pharmaceuticals in 2025-26.
Bafna Pharmaceuticals FAQs
As of 02-2026, the promoter shareholding in Bafna Pharmaceuticals stands at 75% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Bafna Pharmaceuticals is 9.34% and 0% respectively.
The retail shareholding of the Bafna Pharmaceuticals is 15.66%.
Changes in shareholding patterns of Bafna Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Bafna Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Bafna Pharmaceuticals Associated Pages
